Qualigen Therapeutics, Inc. (NASDAQ:QLGN) completed a private placement of 4,500 shares of Series A-3 Preferred Stock, raising $4.5 million. The stock is convertible into 1,607,143 common shares at $2.80 per share. The net proceeds will be used for working capital purposes. The offering was managed by Univest, LLC. The Company plans to file a registration statement with the SEC for the resale of the common shares. Qualigen is a biotech company focused on cancer and infectious disease treatments. Forward-looking statements caution investors about potential risks and uncertainties. For more information, visit www.qlgntx.com.

Read more at GlobeNewswire: Qualigen Therapeutics Announces $4.5 Million Private